Jounce Therapeutics, Inc.
JNCEDelisted May 4, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001640455
Jounce Therapeutics, Inc. was delisted on May 4, 2023; its insiders filed their last Form 4 on May 5, 2023; 84 institutions reported holding it in 13F filings for Q1 2023, worth $64.1M in total; no superinvestor held it.
13F holders, Q3 2021
Institutional positions in Jounce Therapeutics, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 115
- −14 vs. Q2 2021
- Shares held
- 36.4M
- +438.6K (+1.2%) vs. Q2 2021
- Total value
- $270.6M
- +$26.1M (+10.7%) vs. Q2 2021
- New holders
- 11
- 44 more added
- Sold out
- 25
- 35 more reduced
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting JNCE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 1 | $917.8K |
| Q1 2023 | 84 | $64.1M |
| Q4 2022 | 85 | $39.8M |
| Q3 2022 | 102 | $99.5M |
| Q2 2022 | 102 | $129.3M |
| Q1 2022 | 113 | $287.1M |
| Q4 2021 | 124 | $342.9M |
| Q3 2021 | 115 | $270.6M |
| Q2 2021 | 130 | $244.8M |
| Q1 2021 | 124 | $378.3M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Jounce Therapeutics, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| PFM Health Sciences, LP | 3,848,822 | $28.6M | 0.93% | +585,989+18.0% | Added |
| TRV GP III, LLC | 3,048,780 | $22.7M | 4.30% | 00.0% | Unchanged |
| TRV GP II, LLC | 2,697,829 | $20.0M | 88.84% | −1,750,000−39.3% | Reduced |
| OrbiMed Advisors LLC | 2,655,600 | $19.7M | 0.22% | +508,200+23.7% | Added |
| BlackRock Inc. | 2,534,851 | $18.8M | 0.00% | +77,752+3.2% | Added |
| Adage Capital Partners GP, L.L.C. | 2,456,023 | $18.2M | 0.04% | +28,000+1.2% | Added |
| Logos Global Management LP | 2,000,000 | $14.9M | 1.07% | +2,000,000 | New |
| Citadel Advisors LLC | 1,724,251 | $12.8M | 0.01% | −236,350−12.1% | Reduced |
| Vanguard Group Inc | 1,443,429 | $10.7M | 0.00% | +36,604+2.6% | Added |
| RTW Investments, LP | 1,396,203 | $10.4M | 0.16% | +1,396,203 | New |
| Dimensional Fund Advisors LP | 1,047,545 | $7.78M | 0.00% | −179,735−14.6% | Reduced |
| Acadian Asset Management LLC | 888,365 | $6.60M | 0.03% | +184,446+26.2% | Added |
| FMR LLC | 790,934 | $5.88M | 0.00% | 00.0% | Unchanged |
| Erste Asset Management GmbH | 779,587 | $5.79M | 0.11% | +120,000+18.2% | Added |
| Goldman Sachs Group Inc | 673,926 | $5.01M | 0.00% | +509,577+310.1% | Added |
| Sofinnova Investments, Inc. | 637,347 | $4.74M | 0.30% | +12,591+2.0% | Added |
| Geode Capital Management, LLC | 614,430 | $4.57M | 0.00% | +84,915+16.0% | Added |
| State Street Corp | 497,985 | $3.70M | 0.00% | +59,220+13.5% | Added |
| Congress Asset Management Co | 380,934 | $2.83M | 0.02% | +22,535+6.3% | Added |
| Two Sigma Advisers, LP | 376,500 | $2.80M | 0.01% | +158,900+73.0% | Added |
| Northern Trust Corp | 350,647 | $2.60M | 0.00% | −77,238−18.1% | Reduced |
| Candriam Luxembourg S.C.A. | 337,398 | $2.51M | 0.02% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 292,425 | $2.17M | 0.00% | −37,878−11.5% | Reduced |
| Moloney Securities Asset Management, LLC | 282,250 | $2.10M | 0.38% | +265,650+1,600.3% | Added |
| Omega Fund Management, LLC | 275,513 | $2.05M | 0.23% | 00.0% | Unchanged |
| Millennium Management LLC | 241,225 | $1.79M | 0.00% | −217,091−47.4% | Reduced |
| Two Sigma Investments, LP | 222,903 | $1.66M | 0.00% | −74,726−25.1% | Reduced |
| Assenagon Asset Management S.A. | 213,043 | $1.58M | 0.01% | −469,827−68.8% | Reduced |
| Silverarc Capital Management, LLC | 208,559 | $1.55M | 0.90% | −42,085−16.8% | Reduced |
| Price T Rowe Associates Inc | 201,494 | $1.50M | 0.00% | +15,636+8.4% | Added |
| Wells Fargo & Company | 191,726 | $1.42M | 0.00% | +46,815+32.3% | Added |
| Nuveen Asset Management, LLC | 167,060 | $1.30M | 0.00% | +11,299+7.3% | Added |
| Granahan Investment Management Inc | 174,175 | $1.29M | 0.02% | −183,642−51.3% | Reduced |
| Marshall Wace, LLP | 169,686 | $1.26M | 0.01% | −81,792−32.5% | Reduced |
| AQR Capital Management LLC | 167,192 | $1.24M | 0.00% | +11,240+7.2% | Added |
| Credit Suisse AG | 165,863 | $1.23M | 0.00% | −384,699−69.9% | Reduced |
| Mariner, LLC | 149,463 | $1.11M | 0.01% | +80.0% | Added |
| Charles Schwab Investment Management Inc | 143,585 | $1.07M | 0.00% | −114,507−44.4% | Reduced |
| Bank of New York Mellon Corp | 128,079 | $952.0K | 0.00% | +25,811+25.2% | Added |
| Connor, Clark & Lunn Investment Management Ltd. | 120,898 | $898.0K | 0.00% | +48,302+66.5% | Added |
| Schonfeld Strategic Advisors LLC | 116,784 | $867.0K | 0.01% | −13,228−10.2% | Reduced |
| Yorktown Management & Research Co Inc | 113,200 | $841.0K | 0.63% | +56,600+100.0% | Added |
| Panagora Asset Management Inc | 105,696 | $785.0K | 0.00% | +12,829+13.8% | Added |
| Gsa Capital Partners LLP | 96,900 | $720.0K | 0.07% | +44,277+84.1% | Added |
| Pathway Capital Management, LP | 84,763 | $630.0K | 0.30% | +24,484+40.6% | Added |
| Ziegler Capital Management, LLC | 68,780 | $511.0K | 0.02% | −2,317−3.3% | Reduced |
| Alliancebernstein L.P. | 61,900 | $460.0K | 0.00% | 00.0% | Unchanged |
| Jasper Ridge Partners, L.P. | 50,858 | $378.0K | 0.02% | +50,858 | New |
| Principal Financial Group Inc | 46,020 | $342.0K | 0.00% | −1,736−3.6% | Reduced |
| Rhumbline Advisers | 42,573 | $316.0K | 0.00% | +1,167+2.8% | Added |
| New York State Common Retirement Fund | 42,119 | $313.0K | 0.00% | +198+0.5% | Added |
| Barclays PLC | 40,146 | $298.0K | 0.00% | −2,392−5.6% | Reduced |
| Franklin Resources Inc | 39,321 | $292.0K | 0.00% | +39,321 | New |
| State of Wisconsin Investment Board | 38,000 | $282.0K | 0.00% | +1,300+3.5% | Added |
| LPL Financial LLC | 37,685 | $280.0K | 0.00% | +250+0.7% | Added |
| AXA S.A. | 35,800 | $266.0K | 0.00% | +15,600+77.2% | Added |
| D. E. Shaw & Co., Inc. | 34,388 | $256.0K | 0.00% | −44,535−56.4% | Reduced |
| Voya Investment Management LLC | 32,000 | $238.0K | 0.00% | +307+1.0% | Added |
| Bailard, Inc. | 31,952 | $237.0K | 0.01% | 00.0% | Unchanged |
| Grace Capital | 25,928 | $234.0K | 0.14% | +7,259+38.9% | Added |
| Eqis Capital Management, Inc. | 30,639 | $228.0K | 0.02% | +1,420+4.9% | Added |
| Susquehanna Fundamental Investments, LLC | 29,603 | $220.0K | 0.00% | −4,191−12.4% | Reduced |
| Fernwood Investment Management, LLC | 26,684 | $198.0K | 0.07% | +7,463+38.8% | Added |
| Kestra Advisory Services, LLC | 25,450 | $189.0K | 0.00% | 00.0% | Unchanged |
| Captrust Financial Advisors | 24,500 | $182.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 23,705 | $175.0K | 0.00% | −67,026−73.9% | Reduced |
| SG Americas Securities, LLC | 23,393 | $174.0K | 0.00% | +23,393 | New |
| Manufacturers Life Insurance Company, The | 19,784 | $147.0K | 0.00% | +19,784 | New |
| Deutsche Bank AG | 18,957 | $141.0K | 0.00% | −614−3.1% | Reduced |
| American International Group, Inc. | 18,043 | $134.0K | 0.00% | −429−2.3% | Reduced |
| California State Teachers Retirement System | 17,796 | $132.0K | 0.00% | −27,695−60.9% | Reduced |
| Fiduciary Trust Co | 17,722 | $132.0K | 0.00% | +4,492+34.0% | Added |
| Hershey Trust Co | 16,952 | $126.0K | 0.00% | −4,996−22.8% | Reduced |
| ProShare Advisors LLC | 15,170 | $113.0K | 0.00% | −2,584−14.6% | Reduced |
| Parametric Portfolio Associates LLC | 14,372 | $107.0K | 0.00% | +2,793+24.1% | Added |
| Squarepoint Ops LLC | 13,942 | $104.0K | 0.00% | −50,023−78.2% | Reduced |
| Frontier Wealth Management LLC | 13,099 | $97.0K | 0.01% | 00.0% | Unchanged |
| MetLife Investment Management | 12,647 | $94.0K | 0.00% | +12,647 | New |
| Invesco Ltd. | 12,518 | $93.0K | 0.00% | +1,370+12.3% | Added |
| First Manhattan Co | 12,400 | $92.0K | 0.00% | −26,000−67.7% | Reduced |
| Advisory Alpha, LLC | 12,005 | $89.0K | 0.01% | 00.0% | Unchanged |
| Horizon Financial Services, LLC | 12,005 | $89.0K | 0.06% | 00.0% | Unchanged |
| Lazard Asset Management LLC | 12,095 | $89.0K | 0.00% | +12,095 | New |
| Bessemer Group Inc | 11,867 | $88.0K | 0.00% | 00.0% | Unchanged |
| Cubist Systematic Strategies, LLC | 11,577 | $86.0K | 0.00% | −19,555−62.8% | Reduced |
| Navellier & Associates Inc | 11,616 | $86.0K | 0.01% | −451−3.7% | Reduced |
| UBS Group AG | 11,324 | $84.0K | 0.00% | −6,997−38.2% | Reduced |
| Algert Global LLC | 10,200 | $76.0K | 0.01% | +10,200 | New |
| MML Investors Services, LLC | 10,000 | $74.0K | 0.00% | 00.0% | Unchanged |
| Colony Group LLC | 10,000 | $74.0K | 0.00% | 00.0% | Unchanged |
| Metropolitan Life Insurance Co | 9,568 | $71.1K | 0.00% | +9,568 | New |
| BNP Paribas Arbitrage, SA | 9,406 | $69.9K | 0.00% | +6,103+184.8% | Added |
| Bank of America Corp | 9,303 | $69.0K | 0.00% | −3,919−29.6% | Reduced |
| Citigroup Inc | 6,369 | $47.0K | 0.00% | +1,696+36.3% | Added |
| Tower Research Capital LLC (TRC) | 5,502 | $41.0K | 0.00% | −4,711−46.1% | Reduced |
| Royal Bank of Canada | 4,533 | $34.0K | 0.00% | +1,975+77.2% | Added |
| Group One Trading, L.P. | 4,278 | $32.0K | 0.00% | +2,500+140.6% | Added |
| STRS Ohio | 4,100 | $30.0K | 0.00% | −8,100−66.4% | Reduced |
| Meeder Asset Management Inc | 3,578 | $27.0K | 0.00% | +371+11.6% | Added |
| Legal & General Group Plc | 2,629 | $20.0K | 0.00% | 00.0% | Unchanged |